Alpha Blue Ocean, the family office founded by Pierre Vannineuse, is pleased and proud to announce the start of a new partnership with Pharnext. This financing agreement for up to 81 million euros
Investegate announcements from Safe Orthopaedics, Safe Orthopaedics announces the Paris Court of Justice judgment in its favor in the infringement case against Neo Medical
Safe Orthopaedics announces the Paris Court of Justice judgment in its favor in the infringement case against Neo Medical streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Safe Orthopaedics announces CE mark for new Hickory screw
TMPS next-generation range
Launch of a study in Germany with Dr. Jens A.Richolt
Worldwide commercialisation expected in 2022
Éragny-sur-Oise, France, May 27
th, 2021 at 8:55 a.m. CET – Safe Orthopaedics (FR0013467123 – ALSAF), a company specialising in the design, manufacture and marketing of ready-to-use technologies for back surgery, with a particular focus on the safety of emergency vertebral fractures, announced today that it has obtained CE Mark approval for Hickory, a new treatment for the management of osteoporotic patients.
Osteoporosis is a global clinical issue. This disease, which affects a growing number of people, mainly affects those over 50 years of age and has consequences for the treatment of spinal pathologies. Safe Orthopaedics, which recently announced the launch of Sycamore for the treatment of vertebral fractures, is now offering Hickory for the treatment of other pathologies requiring pe
Safe Orthopaedics announces CE mark for new Hickory screw
TMPS next-generation range
Launch of a study in Germany with Dr. Jens A.Richolt
Worldwide commercialisation expected in 2022
Éragny-sur-Oise, France, May 27
th, 2021 at 8:55 a.m. CET - Safe Orthopaedics (FR0013467123 - ALSAF), a company specialising in the design, manufacture and marketing of ready-to-use technologies for back surgery, with a particular focus on the safety of emergency vertebral fractures, announced today that it has obtained CE Mark approval for Hickory, a new treatment for the management of osteoporotic patients.
Osteoporosis is a global clinical issue. This disease, which affects a growing number of people, mainly affects those over 50 years of age and has consequences for the treatment of spinal pathologies. Safe Orthopaedics, which recently announced the launch of Sycamore for the treatment of vertebral fractures, is now offering Hickory for the treatment of other pathologies requiring pedicle scre